CCR7 antibody (AA 2-22)
Quick Overview for CCR7 antibody (AA 2-22) (ABIN285675)
Target
See all CCR7 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 2-22
-
Cross-Reactivity
- Human
-
Cross-Reactivity (Details)
- Peptide sequence is <50 % identical to other mouse chemokine receptors inthis region and crossreacts with human CCR7
-
Immunogen
- CCR7 antibody was raised in goat using a synthetic peptide DPGKPRKNVLVVALLVIFQVC corresponding to amino acid residues 2-22 of mouse CCR7 as the immunogen.
-
Isotype
- IgG1
-
-
-
-
Application Notes
-
ELISA: 1:100,000, FC: 1:10, IC: 1:250, IHC: 1:250, WB: 1:1,000
Optimal conditions should be determined by the investigator. -
Restrictions
- For Research Use only
-
-
-
Concentration
- Lot specific
-
Buffer
- 10 mM KHPO4, pH 7.2, with 140 M NaCl, 1 mg/mL BSA and 0.1 % NaN3.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- -20 °C/-80 °C
-
Storage Comment
- Aliquot and store at -20 °C for short term storage, -70 °C for long-term storage.
-
-
- CCR7 (Chemokine (C-C Motif) Receptor 7 (CCR7))
-
Alternative Name
- CCR7
-
Background
- C-C chemokine receptor type 7 is a protein that in humans is encoded by the CCR7 gene. CCR7 has also recently been designated CD197 (cluster of differentiation 197). The protein encoded by this gene is a member of the G protein-coupled receptor family. This receptor was identified as a gene induced by the Epstein-Barr virus (EBV), and is thought to be a mediator of EBV effects on B lymphocytes. This receptor is expressed in various lymphoid tissues and activates B and T lymphocytes.
-
Pathways
- Regulation of Actin Filament Polymerization, Positive Regulation of Immune Effector Process
Target
-